FDA warns against laparoscopy for uterine fibroids Laparoscopic power morcellation pose a cancer risk, agency says. HealthDay News — Laparoscopic power morcellation for treatment of fibroids could ...
AUSTIN, Texas--(BUSINESS WIRE)--Acessa Health Inc., a women’s health innovator advancing uterine-sparing solutions for symptomatic fibroids, highlights the American Association of Gynecologic ...
† Sum of points reflects complexity and therapeutic options: 0–4 (group I): low complexity hysteroscopic myomectomy; 5–6 (Group II): high complexity hysteroscopic myomectomy, consider preoperative ...
(HealthDay News) — There’s no way to guarantee that laparoscopic power morcellation for uterine fibroid removal or hysterectomy won’t increase the risk of spreading undetected cancer to other parts of ...
Every year, nearly 700,000 American women have surgery to remove their uterus (hysterectomy) or uterine fibroids (myomectomy). A laparoscopic surgical technique once commonly used in these procedures ...
Uterine fibroids occur in an estimated 20 to 80 percent of women. They are most common in women from their 30s to their early 50s. Most women will have small fibroids and no symptoms. If you have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback